Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Capital Employed (2016 - 2026)

Champions Oncology (CSBR) has 14 years of Return on Capital Employed data on record, last reported at 0.26% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 39.0% year-over-year to 0.26%; the TTM value through Oct 2025 reached 0.26%, up 39.0%, while the annual FY2025 figure was 0.85%, 169.0% up from the prior year.
  • Return on Capital Employed reached 0.26% in Q4 2025 per CSBR's latest filing, down from 0.31% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.78% in Q1 2025 and bottomed at 1.72% in Q1 2024.
  • Average Return on Capital Employed over 5 years is 0.21%, with a median of 0.01% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: tumbled -153bps in 2024, then skyrocketed 250bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.03% in 2021, then plummeted by -44bps to 0.01% in 2022, then tumbled by -8104bps to 1.16% in 2023, then surged by 89bps to 0.13% in 2024, then surged by 307bps to 0.26% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.26% in Q4 2025, 0.31% in Q3 2025, and 0.6% in Q2 2025.